Evaluation of minimal residual disease using next-generation flow cytometry in patients with AL amyloidosis.

Blood Cancer J · 2018 · PMC5967299 · PMID 29795385

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

The implications of this observation may be significant, especially if confirmed in larger series.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.